tradingkey.logo

Inotiv Inc

NOTV

1.370USD

-0.080-5.52%
Close 09/19, 16:00ETQuotes delayed by 15 min
47.07MMarket Cap
LossP/E TTM

Inotiv Inc

1.370

-0.080-5.52%
More Details of Inotiv Inc Company
Inotiv, Inc. is a contract research company, which is engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). The DSA segment supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. The RMS segment offer access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
Company Info
Ticker SymbolNOTV
Company nameInotiv Inc
IPO dateNov 25, 1997
CEOMr. Robert W. Leasure, Jr.
Number of employees1977
Security typeOrdinary Share
Fiscal year-endNov 25
Address2701 Kent Ave
CityWEST LAFAYETTE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code47906-1382
Phone13174634527
Websitehttps://www.inotiv.com/
Ticker SymbolNOTV
IPO dateNov 25, 1997
CEOMr. Robert W. Leasure, Jr.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
708.32K
+4.42%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
400.78K
+6.65%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+15.45%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
77.43K
+103.56%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
55.00K
+175.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
49.39K
+393.92%
Mr. Brennan Freeman
Mr. Brennan Freeman
Vice President - Finance, Corporate Controller, Principal Accounting Officer
Vice President - Finance, Corporate Controller, Principal Accounting Officer
--
--
Mr. Robert W. Leasure, Jr.
Mr. Robert W. Leasure, Jr.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Terry Coelho
Ms. Terry Coelho
Independent Director
Independent Director
--
--
Mr. R. Matthew Neff
Mr. R. Matthew Neff
Independent Chairman of the Board
Independent Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. John E. Sagartz, Ph.D.
Dr. John E. Sagartz, Ph.D.
Chief Strategy Officer, Director
Chief Strategy Officer, Director
708.32K
+4.42%
Dr. Adrian Hardy, Ph.D.
Dr. Adrian Hardy, Ph.D.
Chief Commercial Officer
Chief Commercial Officer
400.78K
+6.65%
Mr. John Gregory (Greg) Beattie
Mr. John Gregory (Greg) Beattie
Chief Operating Officer
Chief Operating Officer
186.76K
+15.45%
Dr. Nigel Brown, Ph.D.
Dr. Nigel Brown, Ph.D.
Independent Director
Independent Director
77.43K
+103.56%
Ms. Andrea Castetter
Ms. Andrea Castetter
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
55.00K
+175.00%
Mr. Michael J. Harrington
Mr. Michael J. Harrington
Independent Director
Independent Director
49.39K
+393.92%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
No Data
By RegionUSD
Name
Revenue
Proportion
United States
112.15M
90.21%
Other
7.57M
6.09%
Netherlands
4.60M
3.70%
By Business
By Region
No Data
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Balyasny Asset Management LP
4.82%
The Vanguard Group, Inc.
4.03%
Jermyn Street Associates, L.L.C.
3.67%
Leasure (Robert Jr.)
3.62%
Sagartz (John E)
2.06%
Other
81.81%
Shareholders
Shareholders
Proportion
Balyasny Asset Management LP
4.82%
The Vanguard Group, Inc.
4.03%
Jermyn Street Associates, L.L.C.
3.67%
Leasure (Robert Jr.)
3.62%
Sagartz (John E)
2.06%
Other
81.81%
Shareholder Types
Shareholders
Proportion
Investment Advisor
11.40%
Individual Investor
9.67%
Hedge Fund
8.02%
Investment Advisor/Hedge Fund
4.44%
Corporation
3.67%
Research Firm
1.36%
Bank and Trust
0.15%
Private Equity
0.06%
Other
61.23%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
195
12.88M
37.49%
-4.07M
2025Q1
224
12.80M
37.26%
-4.48M
2024Q4
233
12.65M
38.89%
+1.31M
2024Q3
250
7.31M
26.57%
-8.16M
2024Q2
259
7.59M
28.13%
-9.62M
2024Q1
274
9.86M
38.07%
-7.14M
2023Q4
278
8.23M
31.98%
-10.32M
2023Q3
287
9.98M
38.79%
-9.73M
2023Q2
284
11.42M
44.51%
-8.98M
2023Q1
283
15.00M
60.03%
-7.75M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Balyasny Asset Management LP
1.27M
3.7%
-33.79K
-2.59%
Mar 31, 2025
The Vanguard Group, Inc.
1.29M
3.76%
+204.53K
+18.80%
Mar 31, 2025
Jermyn Street Associates, L.L.C.
1.26M
3.67%
-118.26K
-8.58%
Apr 03, 2024
Leasure (Robert Jr.)
1.24M
3.62%
+429.73K
+52.90%
Mar 14, 2025
Sagartz (John E)
708.32K
2.06%
+30.00K
+4.42%
Mar 14, 2025
Hardy (Adrian)
400.78K
1.17%
+25.00K
+6.65%
Mar 14, 2025
Renaissance Technologies LLC
184.06K
0.54%
-120.19K
-39.50%
Mar 31, 2025
Massar Capital Management, LP
150.00K
0.44%
+150.00K
--
Mar 31, 2025
Vantage Point Financial, LLC.
336.55K
0.98%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
328.48K
0.96%
+90.63K
+38.10%
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI